Latest filing published 01 May 2019 for Revvity, INC..
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Patrick J. Sullivan across 6 companies, led by Hologic Inc, Revvity, Inc. and Insulet Corp. Over a trading history stretching from 28 February 2006 to 30 April 2019, the count stands at 175 filings.
On the open market, the record shows 7 purchases worth €3.4M and 51 sales worth €106.3M. Sales outweigh purchases by €102.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 44 share grants and 67 option exercises.
Half of the purchases are above €294k and half below. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 7 purchases show a median change of -4.0%, with the price up in 43% of them. These figures describe past trades and do not predict future prices.
On 1 May 2019 came the latest disclosure, a share grant in Revvity, Inc. The last insider purchase was made public on 5 December 2016, 3,610 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 151 declarations